Second-Line Therapies in Primary Biliary Cholangitis: A Comparative Review of Obeticholic Acid, Fibrates, Seladelpar, and Elafibranor

Primary biliary cholangitis (PBC) is a chronic autoimmune liver disease marked by cholestasis and progressive fibrosis. While ursodeoxycholic acid (UDCA) remains the first-line therapy, approximately 30–40% of patients have an inadequate biochemical response, increasing the risk of disease progressi...

पूर्ण विवरण

ग्रंथसूची विवरण

मुख्य लेखकों:	Fares Jamal, Amani Elshaer, Mayar H. Alatout, Nour B. Odeh, Amal Youssef, Humam Abo Abdullah, Sandra Elmasry, Tala Shahin, Hussein Abdul Nabi, Astin R. Worden, Talha A. Malik, Blanca C. Lizaola-Mayo
स्वरूप:	Artigo
भाषा:	Inglês
प्रकाशित:	MDPI AG 2025-09-01
श्रृंखला:	Biomedicines
विषय:	primary biliary cholangitis second-line therapy obeticholic acid fenofibrate seladelpar elafibranor
ऑनलाइन पहुंच:	https://www.mdpi.com/2227-9059/13/10/2335
टैग:	टैग जोड़ें कोई टैग नहीं, इस रिकॉर्ड को टैग करने वाले पहले व्यक्ति बनें!